SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001017491-17-000091
Filing Date
2017-08-02
Accepted
2017-08-02 16:04:47
Documents
60
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apri6301710q.htm 10-Q 1021942
2 EXHIBIT 3.1 apri63017ex310.htm EX-3.1 15061
3 EXHIBIT 31.1 apri63017ex311.htm EX-31.1 11895
4 EXHIBIT 32.1 apri63017ex321.htm EX-32.1 5891
  Complete submission text file 0001017491-17-000091.txt   5597579

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT apri-20170630.xml EX-101.INS 858372
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apri-20170630.xsd EX-101.SCH 52003
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apri-20170630_cal.xml EX-101.CAL 72706
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apri-20170630_def.xml EX-101.DEF 349240
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apri-20170630_lab.xml EX-101.LAB 625078
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apri-20170630_pre.xml EX-101.PRE 450943
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22245 | Film No.: 17999894
SIC: 2834 Pharmaceutical Preparations